Ottawa Now - New data says Ottawa's students are falling behind on their immunization records | Unpublished
Hello!
Source Feed: CFRA - 580 - Ottawa
Publication Date: November 3, 2025 - 18:25

Stay informed

Ottawa Now - New data says Ottawa's students are falling behind on their immunization records

November 3, 2025

More than half of today’s students who attend schools in Ottawa and Toronto don’t have up-to-date immunization records. And according to public health records, both cities are falling behind. As of October 12th, Ottawa’s Public Health Unit said that roughly 16,000 students’ immunization records were not up to date, a list that starts in Grade 2 and goes as far as Grade 12. That’s over 66 percent of children in those age groups. Dr. Paul Roumeliotis is the Medical Officer of Health for the Eastern Ontario Health Unit. He sifts through the latest batch of data on today’s Ottawa Now.



Unpublished Newswire

 
Alberta Premier Danielle Smith pointed to her advisers when asked to explain how an Edmonton businessman whose contracts with the province’s health agency are now under scrutiny ended up in a hotel suite with her top lieutenants on the night of the 2023 provincial election. A Globe and Mail investigation published over the weekend examined the links between medical supply company executive Sam Mraiche and Ms. Smith’s government. The Globe found Mr. Mraiche, whose company MHCare was awarded more than $600-million in contracts with Alberta Health Services, had more extensive connections to...
December 1, 2025 - 22:01 | Matthew Scace, Emma Graney | The Globe and Mail
For now, Cole says he walks the perimeter of his home every night, checking for any unwanted visitors and hoping nothing like this happens again.
December 1, 2025 - 21:55 | Victoria Femia | Global News - Canada
More cases of prostate cancer were diagnosed at Stage 4 in recent years compared with about a decade earlier, a development that experts behind a new study suggest could be linked with official recommendations discouraging the use of a hotly debated screening test.The prostate-specific antigen test is a simple blood test that can serve as an early warning signal of cancer in men with no symptoms. But the test also has risks: It can lead to overdiagnosis and overtreatment of slow-growing prostate tumours that might never have caused harm had they remained undiscovered. For that reason, a...
December 1, 2025 - 20:45 | Kelly Grant | The Globe and Mail